About Biocorp
Biocorp is a company based in Issoire (France) founded in 2004 was acquired by Novo Nordisk in June 2023. Biocorp offers products and services including Dispositifs connectés and Dispositifs pharmaceutiques. Biocorp operates in a competitive market with competitors including Insulet, Lyra Therapeutics, TriSalus Life Sciences, Credence MedSystems and Cellectar Biosciences, among others.
- Headquarter Issoire, France
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Novo Nordisk
(Jun 05, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biocorp
Biocorp offers a comprehensive portfolio of products and services, including Dispositifs connectés and Dispositifs pharmaceutiques.
Devices for monitoring and improving patient care in healthcare.
Pharmaceutical tools for drug delivery and management systems.
Funding Insights of Biocorp
Detailed funding history for Biocorp
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Biocorp
Biocorp has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novo Nordisk.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
Locked | Locked | Locked |
Investor details for Biocorp
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocorp
Investment portfolio details for Biocorp
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biocorp
Detailed financials for Biocorp
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocorp Comparisons
Peer comparison for Biocorp
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biocorp
Biocorp operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, TriSalus Life Sciences, Credence MedSystems and Cellectar Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of drug delivery devices to treat cancers
|
|
| Locked | Locked | Locked |
Developer of smart devices for drug delivery
|
|
| Locked | Locked | Locked |
Phospholipid drug conjugates for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Injectables and NCEs for cancer and chronic diseases are developed.
|
Detailed competitors of Biocorp
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocorp
Complete news archive for Biocorp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocorp
Biocorp was founded in 2004.
Biocorp is headquartered in Issoire, France. It is registered at Issoire, Auvergne-rhone-alpes, France.
Founded in 2004, operations are based in Issoire, France, within the pharmaceutical and medical device sector. Drug delivery systems, such as the Newguard Passive Safety System for pre-filled syringes, are produced alongside wireless-enabled devices including the DataPen smart injector, EasyLog sensors for injectors, and InsPair sensors for inhalers. Manufacturing services encompass injection molding, assembly, and packaging, with focus on supply chain and cost efficiencies.
Biocorp's top competitors include Insulet, Lyra Therapeutics and TriSalus Life Sciences.
Biocorp offers Dispositifs connectés and Dispositifs pharmaceutiques.
Biocorp has 1 investor. Key investors include Novo Nordisk.